255 related articles for article (PubMed ID: 32412509)
1. COVID-19 Comes 40 Years After AIDS - Any Lesson?
Soriano V; Barreiro P; Ramos JM; Eirós JM; de Mendoza C
AIDS Rev; 2020 Jul; 22(2):63-77. PubMed ID: 32412509
[TBL] [Abstract][Full Text] [Related]
2. Managing the march of COVID-19: lessons from the HIV and AIDS epidemic.
Whiteside A; Parker W; Schramm M
Afr J AIDS Res; 2020 Jul; 19(2):iii-vi. PubMed ID: 32233915
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
[TBL] [Abstract][Full Text] [Related]
4. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
[TBL] [Abstract][Full Text] [Related]
5. The COVID-19 pandemic.
Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 in Africa: Dampening the storm?
Mbow M; Lell B; Jochems SP; Cisse B; Mboup S; Dewals BG; Jaye A; Dieye A; Yazdanbakhsh M
Science; 2020 Aug; 369(6504):624-626. PubMed ID: 32764055
[No Abstract] [Full Text] [Related]
7. The Wuhan SARS-CoV-2-What's next for China.
Lu H; Stratton CW; Tang YW
J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
[No Abstract] [Full Text] [Related]
8. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
9. [Some learned lessons (or not so much) from COVID-19].
Natal C
J Healthc Qual Res; 2020; 35(4):207-208. PubMed ID: 32646773
[No Abstract] [Full Text] [Related]
10. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
12. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
13. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
Lan SH; Lai CC; Huang HT; Chang SP; Lu LC; Hsueh PR
Int J Antimicrob Agents; 2020 Sep; 56(3):106103. PubMed ID: 32712333
[TBL] [Abstract][Full Text] [Related]
16. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
18. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression drug advice and COVID-19: are we doing more harm than good?
Warraich R; Amani L; Mediwake R; Tahir H
Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589546
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
Lv W; Wu M; Ren Y; Zeng N; Deng P; Zeng H; Zhang Q; Wu Y
J Urol; 2020 Nov; 204(5):918-925. PubMed ID: 32693711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]